once again all be aware that two public health can often leave citizens and countries unable access medicines because there is no incentive for pharmaceutical companies to develop medicines though
Once again, we should all be aware that too many obligations on public health can often leave citizens in poorer countries unable to access medicines, because there is no incentive for pharmaceutical companies to develop medicines for those countries.
Once again, all be aware that too public health can often leave citizens in countries unable access medicines, because there is no incentive for pharmaceutical companies to develop medicines those